Daxor corporation to exhibit at the 43rd international society for heart and lung transplant (ishlt) annual meeting and scientific sessions

Company to showcase three new research studies utilizing blood volume analysis oak ridge, tn, april 13, 2023 (globe newswire) -- daxor corporation (nasdaq: dxr), the global leader in blood volume measurement technology, today announces it will be attending the 43rd international society for heart and lung transplant (ishlt) annual meeting and scientific sessions, which brings together the world's leading experts in heart and lung transplant being held at the colorado convention center, from april 19-22, in denver, co. the company will host a booth and new data will be featured highlighting the applicability of blood volume analysis (bva) titled, “differences in pressure-volume relati onship between obese and non-obese patients with advanced heart failure” (poster #116.531), “relationship between blood volume measures and cardiopulmonary exercise testing performance in advanced heart failure” (poster #117.532), and “differences in cardi opulmonary exercise performance between true anemia and hemodilution in patients with advanced heart failure”(poster #118.537) all posters will be presented in the mile high ballroom.
DXR Ratings Summary
DXR Quant Ranking